Pyxis Oncology: Readouts Ahead, Although Cash Might Dwindle (Rating Downgrade)
Source: SeekingAlpha
2025-09-12 11:44:56 ET
...
Read the full article on Seeking Alpha
For further details see:
Pyxis Oncology: Readouts Ahead, Although Cash Might Dwindle (Rating Downgrade)
Immutep Limited
NASDAQ: PRRUF
PRRUF Trading
-50.45% G/L:
$0.2535 Last:
250 Volume:
$0.2535 Open:
PRRUF Latest News
PRRUF Stock Data
$401,834,253
848,897,531
N/A
21
N/A
Biotechnology & Life Sciences
Healthcare
AU
Sydney
